Clinical Trial Update: Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 prospective, multi-center study evaluating linperlisib in combination with chidamide for relapsed/refractory peripheral T-cell lymphoma is underway,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Linperlisib (linperlisib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Peripheral T Cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN